Showing Results for: “diabetes”

The American Diabetes Association ® (ADA) applauds the Maryland General Assembly for passing Senate Bill 496 allowing Maryland Medicaid to cover full obesity treatments, including weight-loss medications, if the state chooses to do so, and notifies patients. The strong bipartisan support from the Maryland General Assembly was vital to the successful passage of the important policy. The ADA appreciates Maryland Governor Wes Moore for allowing this measure to be enacted. Under the newly passed law, the Maryland Department of Health (MDH) is empowered to offer comprehensive treatment options to

Gold Winner for Best Campaign, Health, Non-Profit; Bronze for Best Brand Campaign, Health The American Diabetes Association ®(ADA) announced today that it has been named a Gold Winner for Best Non-Profit Health Campaign and Bronze Winner for Best Brand Campaign in the Health category in the third Annual Anthem Awards. This year’s Anthem Award Winners were selected from a pool of over 2,000 submissions from 44 countries by the International Academy of Digital Arts and Sciences (IADAS). Anthem judges are intellectually diverse leaders from across the impact industry with expertise that spans

Today, the California Assembly Health Committee passed Assembly Bill 2203 (Nazarian), legislation that will cap insulin co-pays at $50 per 30-day supply of insulin and total out-of-pocket costs for insulin at $100 for those in state-regulated health insurance plans. The legislation also authorizes the California Attorney General to investigate the rising price of insulin in the state. The American Diabetes Association (ADA) is sponsoring the legislation along with the Health Trust. “The American Diabetes Association is appreciative of the support of our bill author Assemblymember Adrin

Waters Bill Would Eliminate Cost-Sharing for Insulin-Dependent Seniors The American Diabetes Association (ADA), announced its strong support today for the Affordable Insulin for the COVID-19 Emergency Act, introduced by Representative Maxine Waters (D-CA-43). The ADA called on all Members of Congress to join the measure’s 25 original co-sponsors. The bill ensures that insulin-dependent Medicare beneficiaries are able to obtain their prescriptions for insulin and associated medical supplies with no copayments, coinsurance, deductibles or other cost-sharing for the duration of the COVID-19

The bill from Rep. Robin Kelly (D-IL) extends protections to low-income and minority communities during COVID-19 The American Diabetes Association® (ADA), the nation’s leading organization for all people living with diabetes, announced its support today for the Ending Health Disparities during COVID-19 (EHDC) Act, introduced by Representative Robin Kelly (D-IL). The list of bill cosponsors includes Reps. Karen Bass (D-CA), Joaquin Castro (D-TX), Judy Chu (D-CA), Jesús “Chuy” García (D-IL), Deb Haaland (D-NM), Barbara Lee (D-CA), Darren Soto (D-FL), Terri Sewell (D-AL), G.K. Butterfield (D-NC)

Pancreatic beta cells that do not produce sufficient insulin in people with type 2 diabetes (T2D) are not permanently damaged during the early stages of the disease and can be restored to normal function through the removal of excess fat in the cells, according to a study entitled “Remission of Type 2 Diabetes for Two Years Is Associated with Full Recovery of Beta-Cell Functional Mass in the Diabetes Remission Clinical Trial (DiRECT)” presented today at the American Diabetes Association’s® (ADA’s) 79th Scientific Sessions®. More than one-third (36%) of the participants who took part in an

Today, the American Diabetes Association® (ADA) announced a collaboration with OpenEvidence, an AI platform delivering evidence-grounded answers to more than 500,000 U.S. health care professionals, to offer improved access to the ADA’s Standards of Care in Diabetes (Standards of Care). The ADA’s Standards of Care is the gold standard for clinical practice, distilling the latest scientific research and clinical trials into actionable guidance for: Diagnosing and treating diabetes in both youth and adults Methods to prevent or delay type 2 diabetes and its associated comorbidities like obesity

The American Diabetes Association® (ADA) announces the release of its 2025 Annual Report. This report highlights our impact across the ADA’s four strategic pillars of research, advocacy, education, and community connections.

My name is Tama and I was diagnosed with type 1 diabetes 43 years ago. It was a month before my sweet 16th birthday, and my family was getting ready to go on a ski trip. I was fortunate to bypass the typical hospital visit, as many with type 1 experience, because once my symptoms started my mother was savvy enough to get me to our pediatrician quickly. They then sent us to an endocrinologist's office in San Diego where I was able to be put on the first trial of recombinant DNA human insulin. When first diagnosed, my mom helped me take insulin injections and took away much of the daily stress

Dr. Kalyani will join the organization on August 11 Today, the American Diabetes Association® (ADA) announced the appointment of Rita Rastogi Kalyani, MD, MHS, as its new chief scientific and medical officer, effective August 11. Following a rigorous national search, Dr. Kalyani was selected for her distinguished scientific leadership, unwavering commitment to improving health outcomes, and vision for advancing the ADA’s mission to prevent and cure diabetes and improve the lives of all people affected by diabetes and living with overweight. Dr. Kalyani is no stranger to the ADA where she has